Nanoplatforms in sepsis storm: Multimodal synergy for precision immunomodulation and pathogen neutralizations

Sepsis, a severe global health challenge characterized by life-threatening organ dysfunction stemming from a dysregulated immune response to drug-resistant pathogens, imposes a substantial disease burden. The intricate nature of sepsis necessitates meticulous drug administration and underscores the...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinxin Wang, Xuemei Wang, Yuxin Cao, Wenming Wang, Dandan Liu, Jingwen Zhang, Yuxiu Chen, Daquan Chen
Format: Article
Language:English
Published: Elsevier 2025-12-01
Series:Pharmaceutical Science Advances
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S277321692500025X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849762159150497792
author Xinxin Wang
Xuemei Wang
Yuxin Cao
Wenming Wang
Dandan Liu
Jingwen Zhang
Yuxiu Chen
Daquan Chen
author_facet Xinxin Wang
Xuemei Wang
Yuxin Cao
Wenming Wang
Dandan Liu
Jingwen Zhang
Yuxiu Chen
Daquan Chen
author_sort Xinxin Wang
collection DOAJ
description Sepsis, a severe global health challenge characterized by life-threatening organ dysfunction stemming from a dysregulated immune response to drug-resistant pathogens, imposes a substantial disease burden. The intricate nature of sepsis necessitates meticulous drug administration and underscores the urgency for advanced drug delivery strategies. This paper presents a comprehensive overview of recent advancements in nanotechnology-driven therapeutic interventions for sepsis, emphasizing innovative approaches such as stimulus-responsive and nano-drug delivery systems that have been applied to tackle sepsis and its associated complications. Drawing from various theories and mechanistic insights into sepsis pathogenesis, we explore novel therapeutic avenues and their potential integration with nano-delivery systems, considering factors such as the microenvironment. We demonstrate how these nano-delivery systems can enhance treatment accuracy and diversity. Furthermore, the synergy between nanomedicine and emerging technologies like CRISPR, CAR-T therapy, AI, microfluidics, microbiome research, and immunotherapy holds the promise to revolutionize sepsis diagnosis, treatment, and management strategies. However, overcoming pathogen resistance, precisely modulating excessive immune response/immunosuppression, and achieving efficient targeted delivery of nanocarriers in complex pathological environments remain core challenges. Future research needs to focus on the development of smarter and more responsive nanoplatforms and deeply explore their deep integration with multiple cutting-edge technologies in order to advance the clinical translation of precision sepsis diagnosis and treatment.
format Article
id doaj-art-098fa30495bf4635aef4a252ffbc0174
institution DOAJ
issn 2773-2169
language English
publishDate 2025-12-01
publisher Elsevier
record_format Article
series Pharmaceutical Science Advances
spelling doaj-art-098fa30495bf4635aef4a252ffbc01742025-08-20T03:05:49ZengElsevierPharmaceutical Science Advances2773-21692025-12-01310008710.1016/j.pscia.2025.100087Nanoplatforms in sepsis storm: Multimodal synergy for precision immunomodulation and pathogen neutralizationsXinxin Wang0Xuemei Wang1Yuxin Cao2Wenming Wang3Dandan Liu4Jingwen Zhang5Yuxiu Chen6Daquan Chen7School of Pharmacy, Yantai University, 30# Qingquan Road, Yantai, 264005, PR ChinaSchool of Pharmacy, Yantai University, 30# Qingquan Road, Yantai, 264005, PR ChinaSchool of Pharmacy, Yantai University, 30# Qingquan Road, Yantai, 264005, PR ChinaSchool of Pharmacy, Yantai University, 30# Qingquan Road, Yantai, 264005, PR ChinaSchool of Pharmacy, Yantai University, 30# Qingquan Road, Yantai, 264005, PR ChinaSchool of Pharmacy, Yantai University, 30# Qingquan Road, Yantai, 264005, PR ChinaShandong University of Traditional Chinese Medicine, Jinan, 250355, PR ChinaSchool of Pharmacy, Yantai University, 30# Qingquan Road, Yantai, 264005, PR China; Corresponding author. Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs, School of Pharmacy, Yantai University, Yantai, 264005, PR China.Sepsis, a severe global health challenge characterized by life-threatening organ dysfunction stemming from a dysregulated immune response to drug-resistant pathogens, imposes a substantial disease burden. The intricate nature of sepsis necessitates meticulous drug administration and underscores the urgency for advanced drug delivery strategies. This paper presents a comprehensive overview of recent advancements in nanotechnology-driven therapeutic interventions for sepsis, emphasizing innovative approaches such as stimulus-responsive and nano-drug delivery systems that have been applied to tackle sepsis and its associated complications. Drawing from various theories and mechanistic insights into sepsis pathogenesis, we explore novel therapeutic avenues and their potential integration with nano-delivery systems, considering factors such as the microenvironment. We demonstrate how these nano-delivery systems can enhance treatment accuracy and diversity. Furthermore, the synergy between nanomedicine and emerging technologies like CRISPR, CAR-T therapy, AI, microfluidics, microbiome research, and immunotherapy holds the promise to revolutionize sepsis diagnosis, treatment, and management strategies. However, overcoming pathogen resistance, precisely modulating excessive immune response/immunosuppression, and achieving efficient targeted delivery of nanocarriers in complex pathological environments remain core challenges. Future research needs to focus on the development of smarter and more responsive nanoplatforms and deeply explore their deep integration with multiple cutting-edge technologies in order to advance the clinical translation of precision sepsis diagnosis and treatment.http://www.sciencedirect.com/science/article/pii/S277321692500025XSepsisNanomedicineDrug deliveryMicrobiomeImmunotherapy
spellingShingle Xinxin Wang
Xuemei Wang
Yuxin Cao
Wenming Wang
Dandan Liu
Jingwen Zhang
Yuxiu Chen
Daquan Chen
Nanoplatforms in sepsis storm: Multimodal synergy for precision immunomodulation and pathogen neutralizations
Pharmaceutical Science Advances
Sepsis
Nanomedicine
Drug delivery
Microbiome
Immunotherapy
title Nanoplatforms in sepsis storm: Multimodal synergy for precision immunomodulation and pathogen neutralizations
title_full Nanoplatforms in sepsis storm: Multimodal synergy for precision immunomodulation and pathogen neutralizations
title_fullStr Nanoplatforms in sepsis storm: Multimodal synergy for precision immunomodulation and pathogen neutralizations
title_full_unstemmed Nanoplatforms in sepsis storm: Multimodal synergy for precision immunomodulation and pathogen neutralizations
title_short Nanoplatforms in sepsis storm: Multimodal synergy for precision immunomodulation and pathogen neutralizations
title_sort nanoplatforms in sepsis storm multimodal synergy for precision immunomodulation and pathogen neutralizations
topic Sepsis
Nanomedicine
Drug delivery
Microbiome
Immunotherapy
url http://www.sciencedirect.com/science/article/pii/S277321692500025X
work_keys_str_mv AT xinxinwang nanoplatformsinsepsisstormmultimodalsynergyforprecisionimmunomodulationandpathogenneutralizations
AT xuemeiwang nanoplatformsinsepsisstormmultimodalsynergyforprecisionimmunomodulationandpathogenneutralizations
AT yuxincao nanoplatformsinsepsisstormmultimodalsynergyforprecisionimmunomodulationandpathogenneutralizations
AT wenmingwang nanoplatformsinsepsisstormmultimodalsynergyforprecisionimmunomodulationandpathogenneutralizations
AT dandanliu nanoplatformsinsepsisstormmultimodalsynergyforprecisionimmunomodulationandpathogenneutralizations
AT jingwenzhang nanoplatformsinsepsisstormmultimodalsynergyforprecisionimmunomodulationandpathogenneutralizations
AT yuxiuchen nanoplatformsinsepsisstormmultimodalsynergyforprecisionimmunomodulationandpathogenneutralizations
AT daquanchen nanoplatformsinsepsisstormmultimodalsynergyforprecisionimmunomodulationandpathogenneutralizations